AstraZeneca, GB0009895292

AstraZeneca stock heads into the open after a 2.84 percent drop

Published on 09/24/2026 at 07:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 23, 2026, AstraZeneca stock stood at USD 163.58 after falling 2.84 percent. The 52-week range was USD 145.79 to USD 212.71; EU approval for Trixeo is the latest dated company event.

Wissenschaftler im weißen Kittel arbeiten in modernem Pharma-Forschungslabor
AstraZeneca plc (ISIN GB0009895292) betreibt moderne Forschungslabore für pharmazeutische Wirkstoffentwicklung und klinische Studien weltweit, Illustration mit AI erstellt.

AstraZeneca stock closed at USD 163.58 on the Nasdaq on September 23, 2026, down 2.84 percent. The close was USD 2.32 below the previous session close, while the Dow Jones Industrial Average fell 0.7 percent to 51,511.59 on the same date.

September 23, 2026 in numbers

AstraZeneca plc (ISIN GB0009895292) traded within a 52-week range of USD 145.79 to USD 212.71 on the Nasdaq. The close was USD 48.?? above the 52-week low and USD 49.13 below the 52-week high. As Seeking Alpha reported on September 23, 2026, the European Commission approved Trixeo Aerosphere for an expanded asthma indication.

September 24, 2026 events

US initial jobless claims, August building permits and August new home sales are scheduled for September 24, 2026. The economic calendar also lists Federal Reserve speeches during the session, including remarks by John Williams, Thomas Barkin and Beth Hammack, according to SVMUU.

Disclaimer...

en | GB0009895292 | ASTRAZENECA | boerse | 70173931 | bgmi